Search

everythinglearnresearchcommunity

for

Search:↓

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Finasteride reverses early hair loss and promotes growth.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Platelet-rich plasma might help with skin aging, ulcers, and hair loss, but more research is needed to prove its effectiveness and safety.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

New treatments for hair loss may target specific pathways and generate new hair follicles.

The gene Msx2 is crucial for hair follicle regeneration during wound healing.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.